Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Lopez, Buenos Aires
Claudio Marcelo Lopez, Buenos Aires AR
| Patent application number | Description | Published |
|---|---|---|
| 20080205612 | TRACKING TRUNK USAGE IN AN ENTERPRISE NETWORK - The present disclosure is directed to a system and method for tracking trunk usage in an enterprise network. In some implementations, a method for identifying trunk expenses includes aggregating data identifying telecommunication services associated with a plurality of trunks in an enterprise network. Charges for the used telecommunication services are identified. The charges are associated with a carrier that provided the telecommunication services. Carrier charges for each of the plurality of the trunks are automatically identified based, at least in part, on the aggregated data and the carrier charges. | 08-28-2008 |
| 20080205613 | UPDATING ROUTING PATTERNS IN AN ENTERPRISE NETWORK - The present disclosure is directed to updating routing patterns in an enterprise network. In some implementations, a method for routing sessions includes identifying information associated with call sessions in an enterprise network. The information includes costs to an enterprise for using carrier services during the call sessions. Routing patterns for call sessions are dynamically updated through at least a portion of the enterprise network based, at least in part, on the costs associated with the call sessions. | 08-28-2008 |
| 20080208603 | REMOTELY MANAGING ENTERPRISE RESOURCES - The present disclosure is directed to a system and method for remotely managing enterprise resources. In some implementations, a method includes remotely receiving information associated with heterogeneous assets in an enterprise network. Transactions for remotely managing the heterogeneous assets are generated in response to at least the information. The management transactions are stored remote from the enterprise network until a request for the management transactions is received from the enterprise network. The management transactions are transmitted to the enterprise network using a single interface. | 08-28-2008 |
| 20080208650 | Tracking Telecommunication Expenses - The present disclosure is directed to tracking telecommunication expenses. In some implementations, a method includes aggregating data associated with telecommunication services used by an employee. One or more policies of an enterprise are automatically identified for evaluating the used services. The enterprise policies are associated with the employee. A violation of one or more enterprise policies is determined based, at least in part, on comparing the aggregated data to the enterprise policies. | 08-28-2008 |
| 20100205287 | REMOTELY MANAGING ENTERPRISE RESOURCES - The present disclosure is directed to a system and method for remotely managing enterprise resources. In some implementations, a method includes remotely receiving information associated with heterogeneous assets in an enterprise network. Transactions for remotely managing the heterogeneous assets are generated in response to at least the information. The management transactions are stored remote from the enterprise network until a request for the management transactions is received from the enterprise network. The management transactions are transmitted to the enterprise network using a single interface. | 08-12-2010 |
Maria Veronica Lopez, Buenos Aires AR
| Patent application number | Description | Published |
|---|---|---|
| 20090312401 | ISOLATED DNA FRAGMENT OF THE SPARC HUMAN PROMOTER AND ITS USE FOR DRIVING THE EXPRESSION OF AN HETEROLOGOUS GENE IN TUMOR CELLS - An isolated DNA sequence corresponding to a region of the SPARC gene human promoter from base pair −513 to base pair +3 5 capable of driving the expression of a heterologous gene of interest, that can be associated to any other promoter sequence, such as radiation responsive sequence, hypoxia responsive sequence and free-radical responsive sequence. The invention also provides constructs and DNA recombinant expression viral vectors, comprising said isolated sequence of the SPARC gene human promoter and at least one heterologous gene operably linked thereto, wherein said promoter sequence drives the expression of the at least one heterologous gene in tumor cells. Pharmaceutical compositions and a method for treating tumors are also provided. | 12-17-2009 |
Ramiro Gabriel Lopez, Buenos Aires AR
| Patent application number | Description | Published |
|---|---|---|
| 20110064277 | Method for interpreting dipping natural fracture and fault planes identified from borehole images - A method of interpreting specific dipping surfaces in earth formations, namely, fracture and fault planes from borehole images. The method is applicable to borehole images obtained from any borehole imaging tool, regardless of tool physics or acquisition type. The interpretation method provides for detailed description of feature s in order to provide a robust framework for subsequent interpretation work. | 03-17-2011 |
Ricardo Augustin Lopez, Buenos Aires AR
| Patent application number | Description | Published |
|---|---|---|
| 20090233989 | Oligonucleotides stimulatory of the mesenchymal stem cell proliferation and uses thereof - Oligonucleotides having the ability to greatly stimulate the proliferation of pluripotent mesenchymal stem cells “in vitro” and “in vivo” of animals, including humans, are disclosed. These oligonucleotides can be used in a wide range of clinical procedures such as (1) regeneration of mesenchymal tissues which have been damaged through acute injury, abnormal genetic expression or acquired disease by inoculation of the ODNs of this invention; (2) treatment of a host with damaged mesenchymal tissue by removal of small aliquots of bone marrow, isolation of their mesenchymal stem cells and treatment of the damaged tissue with MSCs culture-expanded by incubation with one or more of the ODNs of this invention combined with a biocompatible carrier suitable for delivering the MSCs to the damaged body site(s); (3) production “in vitro” of various mesenchymal tissues by directed differentiation of the MSCs culture-expanded by incubation with one or more of the ODNs of this invention, to replace and restore tissue damage or defects with say “in vitro” obtained mesenchymal tissues combined with a biocompatible carrier suitable for delivering the “in vitro” produced tissues to the damaged body site(s); and (4) treatment of a host with abnormal genetic expression with MSCs culture-expanded by incubation with one or more of the ODNs of this invention and transformed by genetic engineering procedures to express a protein able to replace the genetic deffect. | 09-17-2009 |